20 results
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... Medications • SGLT2i ... #Medications #pharmacology ... #pathophysiology ... #endocrinology
Hydroxyurea - Pathophysiology and Benefits in Sickle Cell Disease
 • Decreases number of pain crises (
Hydroxyurea - Pathophysiology ... and Benefits in ... vs. 1) • Fewer ACS ... #SickleCell #pathophysiology ... #pharmacology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology ... Jardiance) - Best risk/benefit ... heart disease • All ... • Euglycemic diabetic ... #endocrinology
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Diabetes Combination ... Metformin + SGLT2 ... /ambcarerx #Diabetes ... Tablets #Oral #DM2 #Pharmacology ... #Pills #Endocrinology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... Benefits of these ... #Inhibitors #Pharmacology ... Medications #DM2 #Diabetes ... #Endocrinology
Glucose-lowering medication in type 2 diabetes - Algorithm

#Diabetes #Medications #Algorithm #Pharmacology #Pharmacotherapy #Hypoglycemic #Management #Endocrinology
medication in type 2 diabetes ... - Algorithm # ... Diabetes #Medications ... #Algorithm #Pharmacology ... Hypoglycemic #Management #Endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... medications has its own benefits ... #pharmacology #pharmacotherapy ... #endocrinology
Diabetes Medication Choice
-Diabetes Medication Choice decision aid cards provide information on medications commonly used to treat
Diabetes Medication ... Choice -Diabetes ... only metformin, SGLT-i ... cardiovascular/mortality benefits ... Reduction #Costs #Pharmacology
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... Control Algorithm ... #2018 #Glycemic #Diabetes ... Control #Medication #Algorithm ... #Endocrinology
Pathogenesis and Pathophysiology of Diabetic Ketoacidosis (DKA)

DKA is a result of an absolute or relative insulin
of Diabetic Ketoacidosis ... counterregulatory hormones act ... #Pathophysiology ... #DKA #Diabetes ... #Endocrinology